# Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas

> **NCT02970448** · EARLY_PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- High Grade Glioma

## Interventions

- **PROCEDURE:** LITT
- **RADIATION:** Radiation therapy
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT02970448
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-24
- **Primary completion:** 2023-11-10
- **Final completion:** 2024-10-25
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02970448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02970448, "Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02970448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*